
Walgreens Boots Alliance Inc WBA stock market quote is a crucial factor for investors to consider. The company's stock has been listed on the New York Stock Exchange (NYSE) since 1996.
As of my last update, the WBA stock price has fluctuated between $45.30 and $60.30. This range gives you an idea of the stock's volatility.
Walgreens Boots Alliance's market capitalization is around $50 billion. This makes it a significant player in the retail and healthcare industries.
Key Data
Walgreens Boots Alliance (WBA) is a publicly traded company with a significant market presence. The company's stock is listed under the ticker symbol WBA.
The current market data for WBA is as follows:
The company's stock has experienced a significant price fluctuation over the past 52 weeks, with a low of $8.08 and a high of $23.77.
Stock Performance
Walgreens Boots Alliance Inc's stock performance has been quite volatile over the years. The company's stock has seen a 9.95% increase in just one week, but a 76.24% decline over the past five years.

Let's take a closer look at the company's recent performance. In the last one month, the stock has increased by 35.39%. This is a significant improvement from the 19.83% increase seen over the past three months.
Here's a summary of the company's stock performance over different time periods:
The company's current stock price is $12.93, with a day range of $12.43 to $13.25. This is a relatively narrow range compared to the year range of $7 to $21.
Annual Financials
Walgreens Boots Alliance's annual financials are a great indicator of the company's overall health and performance. The revenue is expected to reach $169,561 in 2029.
The company's dividend per share is expected to be around $1.21 in 2027, with a dividend yield of 9.32%. This is a significant increase from the previous years, indicating a strong commitment to rewarding shareholders.
The earnings per share (EPS) is projected to be $1.95 in 2029, with a price-to-earnings (P/E) ratio of 6.63. This suggests that the stock is relatively undervalued compared to its peers.

Here's a breakdown of the company's annual financials for the next few years:
The net profit is expected to reach $1,913 in 2029, with a pre-tax profit of $2,163. This indicates a strong growth in profitability over the next few years.
The company's cash flow from operations is expected to reach $2,852 in 2029, with a free cash flow of $1,473. This suggests that the company has a strong ability to generate cash and fund its operations.
Valuation
The valuation of Walgreens Boots Alliance (WBA) is a crucial aspect to consider when evaluating its stock market performance.
The Price to Sales Ratio is 0.054, indicating that the stock is relatively cheap compared to its sales.
The Price to Book Ratio is 0.765, which suggests that the stock is trading at a lower price compared to its book value.
The Price to Cash Flow Ratio is 7.843, indicating that the stock is relatively expensive compared to its cash flow.

The Enterprise Value to EBITDA is 9.541, suggesting that the stock is trading at a higher price compared to its EBITDA.
The Enterprise Value to Sales is 0.274, indicating that the stock is relatively cheap compared to its sales.
Here's a summary of the valuation metrics for WBA:
Efficiency
Walgreens Boots Alliance's efficiency is a mixed bag. Their revenue per employee is a staggering $473,262.821, indicating a significant amount of revenue generated by each employee.
This high revenue per employee is not necessarily a guarantee of success, as we can see from their income per employee, which is a negative $27,679.487. This suggests that the company may be hemorrhaging money at the individual employee level.
Despite this, the company's receivables turnover is a respectable 25.236, indicating that they are able to collect on their outstanding receivables in a relatively timely manner.
Their total asset turnover, on the other hand, is a relatively low 1.662. This suggests that the company is not generating a lot of revenue relative to the assets it has on hand.
Here's a summary of Walgreens Boots Alliance's efficiency metrics:
Capital Structure

Walgreens Boots Alliance (WBA) has a significant amount of debt in its capital structure. The company's total debt to total equity is a staggering 324.011, indicating a high level of leverage.
This high debt-to-equity ratio suggests that WBA relies heavily on debt financing to operate its business. The long-term debt to equity ratio is even higher at 286.089, indicating a significant amount of long-term debt on the company's balance sheet.
WBA's capital structure is also characterized by a relatively high total debt to total assets ratio of 41.762. This means that the company's total debt is a substantial portion of its total assets.
Here's a breakdown of WBA's key capital structure ratios:
Overall, WBA's capital structure is characterized by a high level of debt, which may impact the company's financial flexibility and ability to invest in its business.
Frequently Asked Questions
What is the stock market forecast for Walgreens Boots Alliance?
According to 12 Wall Street analysts, the average price target for Walgreens Boots Alliance is $13.67, representing a 16.84% increase from its current price. This forecast ranges from a high of $22.00 to a low of $9.00.
What is the stock price forecast for WBA in 2025?
Analysts predict WBA's stock price to range between $7.00 and $15.00 USD in 2025, with a median forecast of $9.94 USD. Check the latest estimates for the most up-to-date forecast.
Featured Images: pexels.com